Stay updated on Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check53 days agoChange DetectedThe update indicates a new revision label from v3.4.1 to v3.4.2 with no detectable changes to study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded a Show glossary option and updated footer/version labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision v3.4.0, replacing the earlier lowercase/case variants and older revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page shows a new Revision label (v3.3.4) replacing the previous v3.3.3. This is a UI version update and does not modify any study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.